Set for Boston in September, a region with the highest density of biotech start ups anywhere in the world, BioPharm America 2010 is being organized in close cooperation with the Massachusetts Biotechnology Council to make this event the most productive business development events of the year in North America.
“I do not believe there is a Read more »
The ChinaBio® Partnering Forum 2009 partnering event will host some of the biggest names in the international biotech industry who will tackle the central issues for success in China. Don’t miss your chance to be part of the action, there is still time to get your visa.
Program highlights include:
Partnering in China—the New Frontier: China has Read more »
June 10, 2009
In a new report, venture capitalists said they planned to increase investment in the Asia Pacific region more than in any other.
Read the article here
Read more »
We recently had the opportunity to catch up with Liam Condon, Managing Director of Bayer Healthcare China, to discuss Bayer’s China growth strategy.
Thanks for taking the time out of your busy schedule to speak with partneringNEWS™. With start of the ChinaBio® Partnering Forum only weeks away, we are all interested to learn about Bayer’s approach Read more »
Last week, an acronym surfaced in China life science that hasn’t been heard much lately: IPO. Granted, it was only a rumor, and it was for a drug distribution company, not a drug manufacturer or, an even more unlikely event, for a drug discovery enterprise. But still, it was a sign – perhaps only an Read more »
The New China meets big pharma face-to-face in the first-ever ChinaBio® Partnering Forum, set for June 23, 2009 at the Riverfront Business Hotel in Shanghai.
Leading Chinese institutes, the country’s emerging pharmaceutical companies and a burgeoning community of biotech start-ups will be exchanging profiles and setting one-to-one meetings with international pharmaceutical, biotechnology and academic leaders converging Read more »
Venture capitalists committed USD 337 million to China life science projects during 2008, a decent result in a negative year. Granted, total investment was down 16 percent from USD 400 million in 2007, but it was a tremendous advance over the USD 100 million committed as recently as 2006. Unfortunately, a look below the surface Read more »
Because of the worldwide financial downturn, business activity is shrinking almost universally, though some individual areas are demonstrating relative strength – and we think the life science industry in China is one of those areas. In this series of articles, ChinaBio® presents proprietary data developed by its own team of researchers that explains why we Read more »
Newsletter